Hereditary predisposition to low interleukin‐10 production in children with extended oligoarticular juvenile idiopathic arthritis
Open Access
- 1 May 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 40 (5) , 574-578
- https://doi.org/10.1093/rheumatology/40.5.574
Abstract
Objective. To determine whether children with extended oligoarticular juvenile idiopathic arthritis (JIA) produce less of the anti‐inflammatory cytokine interleukin‐10 (IL‐10) than those with persistent oligoarticular JIA. Methods. We measured IL‐10 production in the parents of children with oligoarticular or extended oligoarticular JIA, from whole‐blood cultures stimulated with lipopolysaccharide. Results. IL‐10 production was lower in the parents of children with extended oligoarticular JIA compared with those of children with oligoarticular JIA (P=0.034). There was an increase in the percentage of ATA‐containing genotypes (i.e. genotypes ATA/ATA, ATA/ACC or ATA/GCC) in the parents of children with extended oligoarticular JIA compared with healthy controls (PConclusions. As approximately 84% of the variation in IL‐10 production is thought to be genetically regulated, these results suggest that stimulated IL‐10 production would be lower in children with extended oligoarticular JIA. Because IL‐10 is an anti‐inflammatory cytokine, this may partly explain why this group of children has more severe disease.Keywords
This publication has 48 references indexed in Scilit:
- Polymorphic haplotypes of the interleukin-10 5? flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritisArthritis & Rheumatism, 1999
- IL-10 Gene Promoter Polymorphisms in Rheumatoid Arthritis: SHORT REPORTScandinavian Journal of Rheumatology, 1998
- AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTEREuropean Journal of Immunogenetics, 1997
- Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugsInternational Immunology, 1995
- Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytesEuropean Journal of Immunology, 1994
- Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation.The Journal of Experimental Medicine, 1994
- Immunoregulatory role of interleukin 10 in rheumatoid arthritis.The Journal of Experimental Medicine, 1994
- Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.The Journal of Experimental Medicine, 1993
- Human interleukin 10 is chemotactic for CD8+ T cells and inhibit CD4+ T cell migrationJournal of Dermatological Science, 1992
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991